Purokivi MK - Search Results

1

Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes.

Purokivi MK, Hirvonen MR, Randell JT, Roponen MH, Meklin TM, Nevalainen AL, Husman TM, Tukiainen HO. Purokivi MK, et al. Eur Respir J. 2001 Dec;18(6):951-8. doi: 10.1183/09031936.01.00201201. Eur Respir J. 2001. PMID: 11829101 Free article.

2

Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum.

Purokivi M, Randell J, Hirvonen MR, Tukiainen H. Purokivi M, et al. Eur Respir J. 2000 Aug;16(2):242-6. doi: 10.1034/j.1399-3003.2000.16b10.x. Eur Respir J. 2000. PMID: 10968498 Free article.

3

Comparison of inflammatory elements in nasal lavage and induced sputum following occupational exposure to moldy-building microbes.

Purokivi M, Hirvonen MR, Roponen M, Randell J, Vahteristo M, Tukiainen H. Purokivi M, et al. Inhal Toxicol. 2002 Jun;14(6):653-62. doi: 10.1080/08958370290084557. Inhal Toxicol. 2002. PMID: 12119074

4

Nitric oxide alone is an insufficient biomarker of exposure to microbes in a moisture-damaged building.

Purokivi M, Hirvonen MR, Randell J, Roponen M, Tukiainen H. Purokivi M, et al. Inhal Toxicol. 2002 Dec;14(12):1279-90. doi: 10.1080/08958370290084917. Inhal Toxicol. 2002. PMID: 12454791

5

Hypertonicity of the challenge solution may increase the diagnostic accuracy of histamine challenge.

Koskela HO, Kontra KM, Purokivi MK, Randell JT. Koskela HO, et al. Among authors: purokivi mk. Respir Med. 2005 Jun;99(6):726-34. doi: 10.1016/j.rmed.2004.10.019. Epub 2004 Nov 25. Respir Med. 2005. PMID: 15878489 Free article.

6

The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels.

Stark HJ, Randell JT, Hirvonen MR, Purokivi MK, Roponen MH, Tukiainen HO. Stark HJ, et al. Among authors: purokivi mk. Eur Respir J. 2005 Nov;26(5):887-93. doi: 10.1183/09031936.05.00061405. Eur Respir J. 2005. PMID: 16264051 Free article. Clinical Trial.

7

Interpretation of cough provoked by airway challenges.

Koskela HO, Kontra KM, Purokivi MK, Randell JT. Koskela HO, et al. Among authors: purokivi mk. Chest. 2005 Nov;128(5):3329-35. doi: 10.1378/chest.128.5.3329. Chest. 2005. PMID: 16304280 Clinical Trial.

8

Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.

Koskela HO, Kiviniemi V, Purokivi MK, Taivainen AH, Tukiainen HO. Koskela HO, et al. Among authors: purokivi mk. Respir Med. 2006 Oct;100(10):1760-6. doi: 10.1016/j.rmed.2006.02.001. Epub 2006 Mar 24. Respir Med. 2006. PMID: 16563715 Free article. Clinical Trial.

9

Short-term and seasonal variations of exhaled and nasal NO in healthy subjects.

Stark H, Purokivi M, Kiviranta J, Randell J, Tukiainen H. Stark H, et al. Respir Med. 2007 Feb;101(2):265-71. doi: 10.1016/j.rmed.2006.05.009. Epub 2006 Jun 22. Respir Med. 2007. PMID: 16797173 Free article.

10

Aspergillus fumigatus challenge increases cytokine levels in nasal lavage fluid.

Stark H, Roponen M, Purokivi M, Randell J, Tukiainen H, Hirvonen MR. Stark H, et al. Inhal Toxicol. 2006 Dec;18(13):1033-9. doi: 10.1080/08958370600904579. Inhal Toxicol. 2006. PMID: 16966303 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters